Pharma, health groups partner to produce Ebola vaccine for clinical trials
Why is the cyclospora parasite behind the US outbreak difficult to trace?
Ebola risk for World Cup is 'extremely low', but US is ready, experts say
Moderna and other groups get $60 million to develop Ebola vaccine
Acting head of US NIH infectious disease institute has left, senators say